Effects of Blood Flow Restriction and Small-Sided Games on Soccer Passing and Dribbling Stability Under Fatigue

This study utilizes a randomized, single-blind, placebo-controlled parallel group design. A total of 40 young male soccer players with systematic training backgrounds will be recruited. Following baseline testing, participants will be randomly assigned to either the BFR-SSG group or the SSG control group.The intervention spans 6 weeks, featuring three standardized 90-minute training sessions per week. The core intervention consists of a 4v4 small-sided game module (4 sets of 4 minutes). During this module, the BFR-SSG group will wear pneumatic cuffs inflated to 80% of their individual Limb Occlusion Pressure (LOP), while the control group will wear uninflated cuffs (0% LOP).Pre- and post-intervention assessments will systematically evaluate physiological adaptations (blood lactate, creatine kinase) , neuromuscular function (Countermovement Jump) , and sport-specific technical stability (Loughborough Soccer Passing Test and a 20m change-of-direction dribbling test). To specifically assess performance under metabolic stress, the technical and neuromuscular tests will be conducted at baseline and immediately following a standardized 45-minute fatigue-inducing protocol (Modified LIST). The primary goal is to quantify the attenuation rate of passing and dribbling performance under fatigue and determine if BFR combined with SSG provides superior chronic adaptations compared to SSG alone

Inclusion criteria

• Young male soccer players. Possess a systematic soccer specific training background and maintain a stable competitive state.

Cleared by the Physical Activity Readiness Questionnaire (PAR-Q), confirming that cardiovascular and metabolic systems can tolerate high-intensity physical testing and blood flow restriction interventions.

Exclusion criteria

• Any recent history of neuromuscular or musculoskeletal system injuries. Current smoking habit. Consumption of any sports nutrition supplements or drinks that could significantly affect muscle performance or neural excitability (e.g., creatine, caffeine, beta-alanine) within 3 months prior to the start of the study and throughout the experimental period.